These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10420599)

  • 1. Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography.
    Floridi A; Trizza V; Paolotti P; Lucarelli C
    J Chromatogr A; 1999 Jun; 846(1-2):65-71. PubMed ID: 10420599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
    Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
    Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
    Miyazaki K; Nagai R; Horiuchi S
    J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
    Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
    J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection.
    Scheijen JL; van de Waarenburg MP; Stehouwer CD; Schalkwijk CG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):610-4. PubMed ID: 19188098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects.
    Odetti P; Fogarty J; Sell DR; Monnier VM
    Diabetes; 1992 Feb; 41(2):153-9. PubMed ID: 1733803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
    Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
    Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily haemodialysis improves indices of protein glycation.
    Floridi A; Antolini F; Galli F; Fagugli RM; Floridi E; Buoncristiani U
    Nephrol Dial Transplant; 2002 May; 17(5):871-8. PubMed ID: 11981076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis techniques and advanced glycation end products.
    Tessitore N; Lapolla A; Aricó CN; Gammaro L; Bernich P; Fedele D
    Contrib Nephrol; 2001; (131):33-9. PubMed ID: 11125561
    [No Abstract]   [Full Text] [Related]  

  • 11. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
    Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
    Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive and specific HPLC method for the determination of total pentosidine concentration in plasma.
    Słowik-Zyłka D; Safranow K; Dziedziejko V; Bukowska H; Ciechanowski K; Chlubek D
    J Biochem Biophys Methods; 2004 Nov; 61(3):313-29. PubMed ID: 15571779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELISA of pentosidine, an advanced glycation end product, in biological specimens.
    Taneda S; Monnier VM
    Clin Chem; 1994 Sep; 40(9):1766-73. PubMed ID: 8070089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
    Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
    Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
    Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
    J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive and specific ELISA for plasma pentosidine.
    Izuhara Y; Miyata T; Ueda Y; Suzuki D; Asahi K; Inagi R; Sakai H; Kurokawa K
    Nephrol Dial Transplant; 1999 Mar; 14(3):576-80. PubMed ID: 10193802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.
    Miyata T; Ueda Y; Shinzato T; Iida Y; Tanaka S; Kurokawa K; van Ypersele de Strihou C; Maeda K
    J Am Soc Nephrol; 1996 Aug; 7(8):1198-206. PubMed ID: 8866413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of furosine and pentosidine in CAPD patients.
    Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
    Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.